Sign in
Join
Home
News
Drug Discovery
Forum
RXM TV
Register
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
RXMonthly
Home
News
Drug Discovery
Nonprofit under pressure to make new TB drug affordable
Roche cancer drug the 3rd approved for pan-tumor use
Novo faces shareholder suit over insulin sales disclosures
Celgene wins approval for drug key to Bristol buyout
BioMarin confirms timeline for hemophilia gene therapy, putting pressure on rivals
Forum
RXM TV
Register
Drug Discovery
Drug Discovery
News
Drug Discovery
Pfizer, Novartis partner in hunt to find drugs for NASH
Neither Pfizer or Novartis are among the handful of companies at the leading edge of NASH drug development, which has yet to advance a...
Editor
-
April 24, 2019
0
Read more
1
2
3
4
Page 4 of 4
Editor
Latest articles
CMS chief declines to provide details on Trump healthcare...
News
Editor
-
August 16, 2019
0
The administration faces increasing pressure to release a concrete healthcare plan as Democratic presidential candidates are eager to keep the national conversation...
Read more
Roche cancer drug the 3rd approved for pan-tumor use
Drug Discovery
Editor
-
August 16, 2019
0
Aimed at the molecular catalysts of tumor growth, targeted therapies are treatment mainstays across a wide range of cancer types.
Read more
Novo faces shareholder suit over insulin sales disclosures
Drug Discovery
Editor
-
August 16, 2019
0
Novo is best known for its insulin products like Levemir (insulin detemir) and Tresiba (insulin degludec), as well as other diabetes treatments...
Read more
Celgene wins approval for drug key to Bristol buyout
Drug Discovery
Editor
-
August 16, 2019
0
Approval of Inrebic, which was previously known as fedratinib, is the first domino to fall in Bristol-Myers bet on Celgene's product pipeline.
Read more
Subscribe to our newsletter
Subscribe